{"id":"https://openalex.org/W2149144667","doi":"https://doi.org/10.1586/14737140.2015.1086647","title":"Cancer therapy using nanoformulated substances: scientific, regulatory and financial aspects","display_name":"Cancer therapy using nanoformulated substances: scientific, regulatory and financial aspects","alternate_titles":[],"publication_year":2015,"publication_date":"2015-09-24","ids":{"openalex":"https://openalex.org/W2149144667","doi":"https://doi.org/10.1586/14737140.2015.1086647","mag":"2149144667","pmid":"https://pubmed.ncbi.nlm.nih.gov/26402250"},"language":"en","primary_location":{"id":"doi:10.1586/14737140.2015.1086647","doi":"https://doi.org/10.1586/14737140.2015.1086647","is_oa":false,"landing_page_url":"https://doi.org/10.1586/14737140.2015.1086647","pdf_url":null,"source":{"id":"https://openalex.org/S93370067","display_name":"Expert Review of Anticancer Therapy","issn_l":"1473-7140","issn":["1473-7140","1744-8328"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Review of Anticancer Therapy","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2149144667"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://hal.sorbonne-universite.fr/hal-01547085","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5013770987","display_name":"Edouard Alphand\u00e9ry","orcid":"https://orcid.org/0000-0002-2952-2270","observed_orcids":["https://orcid.org/0000-0002-2952-2270"]},"institutions":[{"id":"https://openalex.org/I4210145605","display_name":"Institut de min\u00e9ralogie, de physique des mat\u00e9riaux et de cosmochimie","ror":"https://ror.org/05abgg682","country_code":"FR","type":"facility","lineage":["https://openalex.org/I1294671590","https://openalex.org/I2802818602","https://openalex.org/I39804081","https://openalex.org/I4210090127","https://openalex.org/I4210098836","https://openalex.org/I4210123595","https://openalex.org/I4210131494","https://openalex.org/I4210145605","https://openalex.org/I4210166444"]},{"id":"https://openalex.org/I4405264447","display_name":"Universit\u00e9 Pierre-et-Marie-Curie","ror":"https://ror.org/01yvrd251","country_code":"FR","type":"education","lineage":["https://openalex.org/I39804081","https://openalex.org/I4405264447"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"Edouard Alphand\u00e9ry","raw_affiliation_strings":["a 1 Nanobacterie, Inc., 36 Boulevard Flandrin, 75116, Paris, France","b 2 Universit\u00e9 Pierre et Marie Curie, IMPMC, 4 place Jussieu, 75252, Paris, France","Nanobacterie, Inc., 36 Boulevard Flandrin, 75116, Paris, France","Universit\u00e9 Pierre et Marie Curie, IMPMC, 4 place Jussieu, 75252, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"a 1 Nanobacterie, Inc., 36 Boulevard Flandrin, 75116, Paris, France","institution_ids":[]},{"raw_affiliation_string":"b 2 Universit\u00e9 Pierre et Marie Curie, IMPMC, 4 place Jussieu, 75252, Paris, France","institution_ids":["https://openalex.org/I4210145605","https://openalex.org/I4405264447"]},{"raw_affiliation_string":"Nanobacterie, Inc., 36 Boulevard Flandrin, 75116, Paris, France","institution_ids":[]},{"raw_affiliation_string":"Universit\u00e9 Pierre et Marie Curie, IMPMC, 4 place Jussieu, 75252, Paris, France","institution_ids":["https://openalex.org/I4210145605","https://openalex.org/I4405264447"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014109438","display_name":"Pierre Grand-Dewyse","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Pierre Grand-Dewyse","raw_affiliation_strings":["a 1 Nanobacterie, Inc., 36 Boulevard Flandrin, 75116, Paris, France","Nanobacterie, Inc., 36 Boulevard Flandrin, 75116, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"a 1 Nanobacterie, Inc., 36 Boulevard Flandrin, 75116, Paris, France","institution_ids":[]},{"raw_affiliation_string":"Nanobacterie, Inc., 36 Boulevard Flandrin, 75116, Paris, France","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042800807","display_name":"R Lef\u00e8vre","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I148261361","display_name":"Institut de physique du globe de Paris","ror":"https://ror.org/004gzqz66","country_code":"FR","type":"facility","lineage":["https://openalex.org/I1294671590","https://openalex.org/I148261361","https://openalex.org/I204730241","https://openalex.org/I4210148025"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Raphael Lef\u00e8vre","raw_affiliation_strings":["a 1 Nanobacterie, Inc., 36 Boulevard Flandrin, 75116, Paris, France","c 3 Institut de physique du globe de Paris, 1 rue Jussieu, 75238 Paris Cedex 05, France","Institut de physique du globe de Paris, 1 rue Jussieu, 75238 Paris Cedex 05, France","Nanobacterie, Inc., 36 Boulevard Flandrin, 75116, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"a 1 Nanobacterie, Inc., 36 Boulevard Flandrin, 75116, Paris, France","institution_ids":[]},{"raw_affiliation_string":"c 3 Institut de physique du globe de Paris, 1 rue Jussieu, 75238 Paris Cedex 05, France","institution_ids":["https://openalex.org/I148261361"]},{"raw_affiliation_string":"Institut de physique du globe de Paris, 1 rue Jussieu, 75238 Paris Cedex 05, France","institution_ids":["https://openalex.org/I148261361"]},{"raw_affiliation_string":"Nanobacterie, Inc., 36 Boulevard Flandrin, 75116, Paris, France","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073643186","display_name":"Chalani Mandawala","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210123595","display_name":"Mus\u00e9um national d'Histoire naturelle","ror":"https://ror.org/03wkt5x30","country_code":"FR","type":"archive","lineage":["https://openalex.org/I4210123595"]},{"id":"https://openalex.org/I4210145605","display_name":"Institut de min\u00e9ralogie, de physique des mat\u00e9riaux et de cosmochimie","ror":"https://ror.org/05abgg682","country_code":"FR","type":"facility","lineage":["https://openalex.org/I1294671590","https://openalex.org/I2802818602","https://openalex.org/I39804081","https://openalex.org/I4210090127","https://openalex.org/I4210098836","https://openalex.org/I4210123595","https://openalex.org/I4210131494","https://openalex.org/I4210145605","https://openalex.org/I4210166444"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Chalani Mandawala","raw_affiliation_strings":["a 1 Nanobacterie, Inc., 36 Boulevard Flandrin, 75116, Paris, France","d 4 Mus\u00e9um National d'histoire naturelle, IMPMC, 4 Place Jussieu, 75252, Paris, France","Mus\u00e9um National d'histoire naturelle, IMPMC, 4 Place Jussieu, 75252, Paris, France","Nanobacterie, Inc., 36 Boulevard Flandrin, 75116, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"a 1 Nanobacterie, Inc., 36 Boulevard Flandrin, 75116, Paris, France","institution_ids":[]},{"raw_affiliation_string":"d 4 Mus\u00e9um National d'histoire naturelle, IMPMC, 4 Place Jussieu, 75252, Paris, France","institution_ids":["https://openalex.org/I4210123595","https://openalex.org/I4210145605"]},{"raw_affiliation_string":"Mus\u00e9um National d'histoire naturelle, IMPMC, 4 Place Jussieu, 75252, Paris, France","institution_ids":["https://openalex.org/I4210123595","https://openalex.org/I4210145605"]},{"raw_affiliation_string":"Nanobacterie, Inc., 36 Boulevard Flandrin, 75116, Paris, France","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5085373356","display_name":"Micka\u00ebl Durand\u2010Dubief","orcid":"https://orcid.org/0000-0002-8556-4459","observed_orcids":["https://orcid.org/0000-0002-8556-4459"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mickael Durand-Dubief","raw_affiliation_strings":["a 1 Nanobacterie, Inc., 36 Boulevard Flandrin, 75116, Paris, France","Nanobacterie, Inc., 36 Boulevard Flandrin, 75116, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"a 1 Nanobacterie, Inc., 36 Boulevard Flandrin, 75116, Paris, France","institution_ids":[]},{"raw_affiliation_string":"Nanobacterie, Inc., 36 Boulevard Flandrin, 75116, Paris, France","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5013770987"],"corresponding_institution_ids":["https://openalex.org/I4210145605","https://openalex.org/I4405264447"],"apc_list":null,"apc_paid":null,"fwci":0.6385,"has_fulltext":false,"cited_by_count":115,"citation_normalized_percentile":{"value":0.54861111,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":100},"biblio":{"volume":"15","issue":"10","first_page":"1233","last_page":"1255"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.9937000274658203,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.9937000274658203,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T13202","display_name":"Pharmacology and Nanomedicine Research","score":0.0017000000225380063,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T14089","display_name":"Nanotechnology research and applications","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2500","display_name":"General Materials Science"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/nanomedicine","display_name":"nanomedicine","score":0.8859999775886536},{"id":"https://openalex.org/keywords/drug-regulation","display_name":"drug regulation","score":0.6039999723434448},{"id":"https://openalex.org/keywords/medical-device-classification","display_name":"medical device classification","score":0.5550000071525574},{"id":"https://openalex.org/keywords/intellectual-property","display_name":"intellectual property","score":0.9340000152587891},{"id":"https://openalex.org/keywords/drug-development","display_name":"drug development","score":0.42800000309944153},{"id":"https://openalex.org/keywords/drug-toxicity","display_name":"drug toxicity","score":0.5759999752044678},{"id":"https://openalex.org/keywords/targeted-drug-delivery","display_name":"targeted drug delivery","score":0.4490000009536743},{"id":"https://openalex.org/keywords/drug-metabolism","display_name":"drug metabolism","score":0.3540000021457672},{"id":"https://openalex.org/keywords/nab-paclitaxel","display_name":"nab-paclitaxel","score":0.6190000176429749},{"id":"https://openalex.org/keywords/trastuzumab-emtansine","display_name":"trastuzumab emtansine","score":0.6650000214576721},{"id":"https://openalex.org/keywords/pegylated-interferon","display_name":"pegylated interferon","score":0.6240000128746033},{"id":"https://openalex.org/keywords/gold-nanoparticles","display_name":"gold nanoparticles","score":0.5649999976158142},{"id":"https://openalex.org/keywords/liposomal-doxorubicin","display_name":"liposomal doxorubicin","score":0.6570000052452087},{"id":"https://openalex.org/keywords/liposomal-irinotecan","display_name":"liposomal irinotecan","score":0.5929999947547913}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6809343099594116},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.4603085517883301},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.45767566561698914},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.20907562971115112}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D004335","descriptor_name":"Drug and Narcotic Control","qualifier_ui":"Q000331","qualifier_name":"legislation & jurisprudence","is_major_topic":false},{"descriptor_ui":"D004355","descriptor_name":"Drug Stability","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D012995","descriptor_name":"Solubility","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014018","descriptor_name":"Tissue Distribution","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015195","descriptor_name":"Drug Design","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016503","descriptor_name":"Drug Delivery Systems","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D053758","descriptor_name":"Nanoparticles","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1586/14737140.2015.1086647","doi":"https://doi.org/10.1586/14737140.2015.1086647","is_oa":false,"landing_page_url":"https://doi.org/10.1586/14737140.2015.1086647","pdf_url":null,"source":{"id":"https://openalex.org/S93370067","display_name":"Expert Review of Anticancer Therapy","issn_l":"1473-7140","issn":["1473-7140","1744-8328"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Review of Anticancer Therapy","raw_type":"journal-article"},{"id":"pmid:26402250","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/26402250","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert review of anticancer therapy","raw_type":"Journal Article"},{"id":"pmh:oai:HAL:hal-01547085v1","doi":null,"is_oa":true,"landing_page_url":"https://hal.sorbonne-universite.fr/hal-01547085","pdf_url":null,"source":{"id":"https://openalex.org/S4306402512","display_name":"HAL","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4405252976","host_organization_name":"Centre pour la Communication Scientifique Directe","host_organization_lineage":["https://openalex.org/I4405252976"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Expert Review of Anticancer Therapy, 2015, 15 (10), pp.1233 - 1255. &#x27E8;10.1586/14737140.2015.1086647&#x27E9;","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"pmh:oai:HAL:hal-01547085v1","doi":null,"is_oa":true,"landing_page_url":"https://hal.sorbonne-universite.fr/hal-01547085","pdf_url":null,"source":{"id":"https://openalex.org/S4306402512","display_name":"HAL","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4405252976","host_organization_name":"Centre pour la Communication Scientifique Directe","host_organization_lineage":["https://openalex.org/I4405252976"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Expert Review of Anticancer Therapy, 2015, 15 (10), pp.1233 - 1255. &#x27E8;10.1586/14737140.2015.1086647&#x27E9;","raw_type":"info:eu-repo/semantics/article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9391000270843506}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":119,"referenced_works":["https://openalex.org/W98748465","https://openalex.org/W1559459501","https://openalex.org/W1560040777","https://openalex.org/W1654053800","https://openalex.org/W1730821295","https://openalex.org/W1751675114","https://openalex.org/W1911376378","https://openalex.org/W1956382989","https://openalex.org/W1965495927","https://openalex.org/W1966174640","https://openalex.org/W1966597723","https://openalex.org/W1967082864","https://openalex.org/W1968337772","https://openalex.org/W1972840121","https://openalex.org/W1975016136","https://openalex.org/W1975071040","https://openalex.org/W1975309857","https://openalex.org/W1976797458","https://openalex.org/W1976844172","https://openalex.org/W1980486524","https://openalex.org/W1982671558","https://openalex.org/W1985259498","https://openalex.org/W1989230986","https://openalex.org/W1990271699","https://openalex.org/W1992498237","https://openalex.org/W1992743812","https://openalex.org/W1993013498","https://openalex.org/W1994656833","https://openalex.org/W1999626926","https://openalex.org/W2005464092","https://openalex.org/W2006393905","https://openalex.org/W2007479294","https://openalex.org/W2013957185","https://openalex.org/W2019063529","https://openalex.org/W2022290794","https://openalex.org/W2024075791","https://openalex.org/W2024089514","https://openalex.org/W2024787650","https://openalex.org/W2026798351","https://openalex.org/W2028745823","https://openalex.org/W2029839190","https://openalex.org/W2030197062","https://openalex.org/W2030380916","https://openalex.org/W2032909177","https://openalex.org/W2034550161","https://openalex.org/W2034671312","https://openalex.org/W2036755095","https://openalex.org/W2040648721","https://openalex.org/W2042249858","https://openalex.org/W2043009832","https://openalex.org/W2044884111","https://openalex.org/W2046851174","https://openalex.org/W2046906914","https://openalex.org/W2048456734","https://openalex.org/W2054849397","https://openalex.org/W2058865733","https://openalex.org/W2059017383","https://openalex.org/W2062228279","https://openalex.org/W2065301020","https://openalex.org/W2066535225","https://openalex.org/W2066936530","https://openalex.org/W2069676654","https://openalex.org/W2070825008","https://openalex.org/W2071796544","https://openalex.org/W2072714492","https://openalex.org/W2073565115","https://openalex.org/W2077613399","https://openalex.org/W2078628247","https://openalex.org/W2078729915","https://openalex.org/W2080202676","https://openalex.org/W2082225136","https://openalex.org/W2085282449","https://openalex.org/W2085365429","https://openalex.org/W2088223764","https://openalex.org/W2093324007","https://openalex.org/W2093807603","https://openalex.org/W2097903633","https://openalex.org/W2103362199","https://openalex.org/W2106810047","https://openalex.org/W2107436598","https://openalex.org/W2108471741","https://openalex.org/W2108853891","https://openalex.org/W2109778051","https://openalex.org/W2112966923","https://openalex.org/W2113495324","https://openalex.org/W2114488174","https://openalex.org/W2115712044","https://openalex.org/W2119666864","https://openalex.org/W2119815276","https://openalex.org/W2120922439","https://openalex.org/W2121565126","https://openalex.org/W2123822349","https://openalex.org/W2124684091","https://openalex.org/W2124971904","https://openalex.org/W2125424530","https://openalex.org/W2134040626","https://openalex.org/W2135486162","https://openalex.org/W2135985260","https://openalex.org/W2141960867","https://openalex.org/W2142483254","https://openalex.org/W2143252722","https://openalex.org/W2144536924","https://openalex.org/W2145240921","https://openalex.org/W2145453007","https://openalex.org/W2145921425","https://openalex.org/W2151800411","https://openalex.org/W2153017356","https://openalex.org/W2155289716","https://openalex.org/W2158018814","https://openalex.org/W2163011235","https://openalex.org/W2164918134","https://openalex.org/W2169498622","https://openalex.org/W2313223284","https://openalex.org/W2326977847","https://openalex.org/W2515662174","https://openalex.org/W2761767314","https://openalex.org/W2912246241","https://openalex.org/W4232171317","https://openalex.org/W4242036463"],"related_works":["https://openalex.org/W3137442841","https://openalex.org/W4313891341","https://openalex.org/W3009682486","https://openalex.org/W2805417225","https://openalex.org/W4386068272","https://openalex.org/W7154889701","https://openalex.org/W4313650425","https://openalex.org/W4324285182","https://openalex.org/W4402161760","https://openalex.org/W2536287564"],"abstract_inverted_index":{"Several":[0],"nanoformulated":[1],"anti-cancer":[2,31],"substances":[3,27,42],"are":[4,127],"currently":[5],"commercialized":[6],"or":[7,96,109],"under":[8],"development.":[9,134],"Pre-clinical":[10],"and":[11,22,63,81,100,123],"clinical":[12],"results":[13],"have":[14],"revealed":[15],"better":[16],"properties,":[17,87],"that":[18,126],"is,":[19],"larger":[20],"efficacy":[21],"lower":[23],"toxicity":[24],"for":[25,29],"these":[26,41],"than":[28],"conventional":[30],"treatments.":[32],"Here,":[33],"we":[34],"review":[35],"the":[36],"development":[37],"of":[38,40,94],"several":[39],"such":[43,88],"as":[44,89,106,118,120],"Marqibo,":[45],"Myocet,":[46],"Doxil,":[47],"DaunoXome,":[48],"MM398,":[49],"MM302,":[50],"Mepact,":[51],"Versamune,":[52],"Thermodox,":[53],"Depocyt,":[54],"Livatag,":[55],"Abraxane,":[56],"Eligard,":[57],"Opaxio,":[58],"Zinostatin":[59],"Stimalamer":[60],"(SMANCS),":[61],"Pegasys":[62],"PegIntron,":[64],"BIND-014,":[65],"CRLX-101,":[66],"Oncaspar,":[67],"Neulasta,":[68],"Aurimmune,":[69],"Auroshell,":[70],"AuNPs,":[71],"Nanotherm,":[72],"NanoXray,":[73],"Magnetosome":[74],"chains,":[75],"Kadcyla":[76],"(T-DM1),":[77],"Ontak":[78],"(DAB/IL2),":[79],"Gendicine":[80],"Curcumin.":[82],"We":[83,102],"describe":[84],"their":[85,90,104,111,132],"specific":[86],"stability,":[91],"solubility,":[92],"mean":[93],"administration":[95],"targeting,":[97],"distribution,":[98],"metabolism":[99],"toxicity.":[101],"discuss":[103],"categorization":[105],"medical":[107],"devices":[108],"drugs,":[110],"fabrication":[112],"process":[113],"within":[114],"a":[115],"regulatory":[116],"environment":[117],"well":[119],"intellectual":[121],"property":[122],"financial":[124],"aspects":[125],"all":[128],"essential":[129],"to":[130],"enable":[131],"industrial":[133]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2149144667","counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":9},{"year":2024,"cited_by_count":12},{"year":2023,"cited_by_count":10},{"year":2022,"cited_by_count":12},{"year":2021,"cited_by_count":13},{"year":2020,"cited_by_count":10},{"year":2019,"cited_by_count":12},{"year":2018,"cited_by_count":10},{"year":2017,"cited_by_count":17},{"year":2016,"cited_by_count":6},{"year":2015,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
